Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GW Pharmaceuticals PLC (NASDAQ:GWPH)

120.75
BATS BZX Real-Time Price
As of 1:15pm ET
 -0.42 / -0.35%
Today’s Change
69.12
Today|||52-Week Range
137.88
+8.05%
Year-to-Date
These 3 Stocks Have Tripled Your Money Over the Past Year
Mar 14 / MotleyFool.com - Paid Partner Content
No Way! A Profitable Marijuana Stock?
Mar 13 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close121.17
Today’s open120.47
Day’s range120.00 - 122.04
Volume6,826
Average volume (3 months)415,585
Market cap$3.1B
Dividend yield--
Data as of 1:15pm ET, 03/27/2017

Growth & Valuation

Earnings growth (last year)-19.04%
Earnings growth (this year)-39.79%
Earnings growth (next 5 years)-50.35%
Revenue growth (last year)-66.86%
P/E ratio--
Price/Sales205.08
Price/Book5.89

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc-1.31-1.86%
PBHPrestige Brands Hold...+0.08+0.14%
RAREUltragenyx Pharmaceu...+0.18+0.26%
ICPTIntercept Pharmaceut...+1.07+0.92%
Data as of 1:17pm ET, 03/27/2017

Financials

Next reporting dateMay 23, 2017
EPS forecast (this quarter)-$1.34
Annual revenue (last year)$14.6M
Annual profit (last year)-$90.0M
Net profit margin-617.13%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Justin D. Gover
Chief Operating Officer &
Executive Director
Christopher John Tovey
Corporate headquarters
Cambridge, Cambridgeshire

Forecasts


Search for Jobs